Product
OXU-001
Aliases
DEXAspheres®
1 clinical trial
1 indication
Indication
Diabetic Macular EdemaClinical trial
A Multi-Center, Randomized, Parallel-Group, Phase 2, Masked, Three-Arm Trial to Compare Safety, Tolerability, Efficacy, and Durability of Two Dose Levels of Suprachoroidal Sustained-Release OXU-001 (Dexamethasone Microspheres; DEXAspheres®) Using the Oxulumis® Illuminated Microcatheterization Device Compared With Intravitreal Dexamethasone Implant (OZURDEX®) in Subjects With Diabetic Macular Edema (OXEYE)Status: Active (not recruiting), Estimated PCD: 2024-11-30